Search Results - "Palumbo, Francis B"

Mapping expanded prostate cancer index composite to EQ5D utilities to inform economic evaluations in prostate cancer: Secondary analysis of NRG/RTOG 0415 by Khairnar, Rahul, Pugh, Stephanie L, Sandler, Howard M, Lee, W Robert, Villalonga Olives, Ester, Mullins, C Daniel, Palumbo, Francis B, Bruner, Deborah W, Shaya, Fadia T, Bentzen, Soren M, Shah, Amit B, Malone, Shawn C, Michalski, Jeff M, Dayes, Ian S, Seaward, Samantha A, Albert, Michele, Currey, Adam D, Pisansky, Thomas M, Chen, Yuhchyau, Horwitz, Eric M, DeNittis, Albert S, Feng, Felix Y, Mishra, Mark V

“…The Expanded Prostate Cancer Index Composite (EPIC) is the most commonly used patient reported outcome (PRO) tool in prostate cancer (PC) clinical trials, but…”
Get full text

Antiparkinson Drug Use and Adherence in Medicare Part D Beneficiaries With Parkinson’s Disease by Wei, Yu-Jung, PhD, Palumbo, Francis B., JD, PhD, Simoni-Wastila, Linda, PhD, Shulman, Lisa M., MD, Stuart, Bruce, PhD, Beardsley, Robert, PhD, Brown, Clayton, PhD

“…Abstract Background Antiparkinson drugs (APDs) are the mainstay of managing Parkinson’s disease (PD). However, there is paucity of evidence documenting…”
Get full text

Antiparkinson Drug Adherence and Its Association with Health Care Utilization and Economic Outcomes in a Medicare Part D Population by Wei, Yu-Jung, PhD, Palumbo, Francis B., PhD, Simoni-Wastila, Linda, PhD, Shulman, Lisa M., MD, Stuart, Bruce, PhD, Beardsley, Robert, PhD, Brown, Clayton H., PhD

“…Abstract Objectives We examine the associations of adherence to antiparkinson drugs (APDs) with health care utilization and economic outcomes among patients…”
Get full text

The DTC microbiome testing industry needs more regulation by Hoffmann, Diane E, von Rosenvinge, Erik C, Roghmann, Mary-Claire, Palumbo, Francis B, McDonald, Daniel, Ravel, Jacques

“…Tests lack analytical and clinical validity, requiring more federal oversight to prevent consumer harm…”
Get full text

The Impact of Regulatory Policies on the Future of Fecal Microbiota Transplantation by Khoruts, Alexander, Hoffmann, Diane E., Palumbo, Francis B.

“…In this article, the authors explore the impact of a potential future regulatory decision by FDA whether or not to continue its enforcement discretion policy…”
Get full text

A proposed definition of microbiota transplantation for regulatory purposes by Hoffmann, Diane E., Palumbo, Francis B., Ravel, Jacques, Rowthorn, Virginia, von Rosenvinge, Erik

“…The advent of fecal microbiota transplantation (FMT) and the prospect of other types of microbiota transplants (MT), e.g. vaginal, skin, oral and nasal, are…”
Get full text

Policy implications of drug importation by Palumbo, Francis B., PhD, Esq, Mullins, C. Daniel, PhD, Slagle, Ashley F., MS, Rizer, Jessica, Esq

“…Abstract Background: Importation of prescription drugs into the United States has been a major health policy issue for some time. The original objective of…”
Get full text

White Paper: Value of Specialty Certification in Pharmacy by Pradel, Françoise G., Palumbo, Francis B., Flowers, Louis, Mullins, C. Daniel, Haines, Stuart T., Roffman, David S.

“…To address the value of Board of Pharmaceutical Specialties (BPS) certification, particularly as perceived by different stakeholders (pharmacists, employers,…”
Get full text

Relationships between antiparkinson medication nonadherence, regimen modifications, and healthcare utilization and expenditures by Wei, Yu-Jung, Palumbo, Francis B, Simoni-Wastila, Linda, Shulman, Lisa M, Stuart, Bruce, Beardsley, Robert, Brown, Clayton

“…Abstract Objectives To examine 1) the effect of prior antiparkinson drug (APD) nonadherence on subsequent APD regimen modifications; and 2) the influence of…”
Get full text

Methodological Comparison of Mapping the Expanded Prostate Cancer Index Composite to EuroQoL-5D-3L Using Cross-Sectional and Longitudinal Data: Secondary Analysis of NRG/RTOG 0415 by Khairnar, Rahul, DeMora, Lyudmila, Sandler, Howard M, Lee, W Robert, Villalonga-Olives, Ester, Mullins, C Daniel, Palumbo, Francis B, Bruner, Deborah W, Shaya, Fadia T, Bentzen, Soren M, Shah, Amit B, Malone, Shawn, Michalski, Jeff M, Dayes, Ian S, Seaward, Samantha A, Albert, Michele, Currey, Adam D, Pisansky, Thomas M, Chen, Yuhchyau, Horwitz, Eric M, DeNittis, Albert S, Feng, Felix, Mishra, Mark V

“…To compare the predictive ability of mapping algorithms derived using cross-sectional and longitudinal data. This methodological assessment used data from a…”
Get more information

Racial/ethnic and age disparities in chemotherapy selection for colorectal cancer by Obeidat, Nour A, Pradel, Francoise G, Zuckerman, Irene H, Trovato, James A, Palumbo, Francis B, DeLisle, Sylvain, Mullins, C Daniel

“…To test the hypotheses that African American patients and older patients with stage IV colorectal cancer were less likely to receive newer chemotherapy agents…”
Get full text

Formulary tier placement for commonly prescribed branded drugs: benchmarking and creation of a preferred placement index by Mullins, C Daniel, Palumbo, Francis B, Saba, Mojdeh

“…To examine the relative preferred placement of commonly dispensed prescription drugs and to assess variations in drug coverage across a convenience sample of…”
Get full text

Variability And Growth In Spending For Outpatient Specialty Pharmaceuticals by Mullins, C. Daniel, DeVries, Andrea R, Hsu, Van Doren, Meng, Fanlun, Palumbo, Francis B

“…Specialty pharmaceuticals are a unique group of drug agents used to treat complex clinical conditions. Many specialty pharmaceuticals are biological in nature…”
Get full text

The Development of Direct-to-Consumer Prescription Drug Advertising Regulation by Palumbo, Francis B., Mullins, C. Daniel

Get full text

The impact of pipeline drugs on drug spending growth by Mullins, C D, Wang, J, Palumbo, F B, Stuart, B

“…Among all components of escalating health care expenditures, spending on prescription drugs is among those growing the fastest. The drug spending growth rate…”
Get full text

The effect of managed care on prescription drug costs and benefits by Lyles, A, Palumbo, F B

“…This review discusses the approaches to prescription drug payment practices taken by managed care to influence drug use and costs, and presents the research…”
Get full text

ISPOR Code of Ethics for Researchers Background Article—Report of the ISPOR Task Force on Code of Ethics for Researchers by Palumbo, Francis B., Barnes, Rod, Deverka, Patricia, McGhan, William, Mullany, Lawrence, Wertheimer, Albert

“…In 2001, ISPOR convened a Task Force on Code of Ethics for Researchers (The Task Force). This Task Force was to build on the previous work of ISPOR Health…”
Get full text

The Future of Stool Banks: A Premature Death? by Hoffmann, Diane E., Langel, Felicia D., Palumbo, Francis B., von Rosenvinge, Erik C.

“…This Article examines whether there is a future for stool banks that provide stool for fecal microbiota transplants to treat recurrent Clostridiodes difficile…”
Get full text

Criteria to request pharmacoeconomic data and data sources for hospital formulary decisions by KULSOMBOON, Vithaya, PALUMBO, Francis B, MULLINS, C. Daniel

Get full text

Government, Big Pharma, and the People: A Century of Dis-Ease by Palumbo, Francis B

“…Palumbo reviews Government, Big Pharma, and the People: A Century of Dis-Ease by Mickey C. Smith, Kolassa E M, and Pray W S…”
Get full text